SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,883,136 | +2741.5% | 528,821 | +22166.1% | 0.07% | +2366.7% |
| Q1 2018 | $383,000 | -98.5% | 2,375 | -98.5% | 0.00% | -98.5% |
| Q4 2017 | $25,634,000 | +271.3% | 155,629 | +40.5% | 0.20% | +292.3% |
| Q3 2017 | $6,903,000 | +2.6% | 110,797 | +31.2% | 0.05% | -7.1% |
| Q2 2017 | $6,726,000 | +26.2% | 84,449 | +12.6% | 0.06% | +30.2% |
| Q1 2017 | $5,330,000 | +110.7% | 75,000 | -5.0% | 0.04% | +87.0% |
| Q1 2016 | $2,530,000 | +45.5% | 78,917 | +66.1% | 0.02% | -23.3% |
| Q4 2014 | $1,739,000 | -44.6% | 47,515 | -52.3% | 0.03% | -53.8% |
| Q3 2014 | $3,140,000 | – | 99,674 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |